GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes. Social media platforms’ users started promoting semaglutide/Ozempic as a weight-loss treatment, and the...

Full description

Bibliographic Details
Main Authors: Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Brain Sciences
Subjects:
GLP-1 receptor agonists
semaglutide
mental health
depression
anxiety
sleep disorders
Online Access:https://www.mdpi.com/2076-3425/13/11/1503

Similar Items

Similar Items